CCL

Összesen 2 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM101524
035-os BibID:(cikkazonosító)949 (WoS)000801949300001 (Scopus)85129502844
Első szerző:Borbély Katalin
Cím:PET/MRI in the Presurgical Evaluation of Patients with Epilepsy: A Concordance Analysis / Borbély Katalin, Emri Miklós, Kenessey István, Tóth Márton, Singer Júlia, Barsi Péter, Vajda Zsolt, Pál Endre, Tóth Zoltán, Beyer Thomas, Dóczi Tamás, Bajzik Gábor, Fabó Dániel, Janszky József, Jordán Zsófia, Fajtai Dániel, Kelemen Anna, Juhos Vera, Wintermark Max, Nagy Ferenc, Moizs Mariann, Nagy Dávid, Lückl János, Repa Imre
Dátum:2022
ISSN:2227-9059
Megjegyzések:The aim of our prospective study was to evaluate the clinical impact of hybrid [18F]-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging ([18F]-FDG PET/MRI) on the decision workflow of epileptic patients with discordant electroclinical and MRI data. A novel mathematical model was introduced for a clinical concordance calculation supporting the classification of our patients by subgroups of clinical decisions. Fifty-nine epileptic patients with discordant clinical and diagnostic results or MRI negativity were included in this study. The diagnostic value of the PET/MRI was compared to other modalities of presurgical evaluation (e.g., electroclinical data, PET, and MRI). The results of the population-level statistical analysis of the introduced data fusion technique and concordance analysis demonstrated that this model could be the basis for the development of a more accurate clinical decision support parameter in the future. Therefore, making the establishment of "invasive" (operable and implantable) and "not eligible for any further invasive procedures" groups could be much more exact. Our results confirmed the relevance of PET/MRI with the diagnostic algorithm of presurgical evaluation. The introduction of a concordance analysis could be of high importance in clinical and surgical decision-making in the management of epileptic patients. Our study corroborated previous findings regarding the advantages of hybrid PET/MRI technology over MRI and electroclinical data.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
PET/MRI
epilepsy
Megjelenés:Biomedicines. - 10 : 5 (2022), p. 1-14. -
További szerzők:Emri Miklós (1962-) (fizikus) Kenessey István Tóth Márton (1960-) (neurológus) Singer Júlia Barsi Péter Vajda Zsolt Pál Endre Tóth Zoltán Beyer, Thomas Dóczi Tamás Bajzik Gábor (1968-) (orvos) Fabó Dániel Janszky József Jordán Zsófia Fajtai Dániel Kelemen Anna Juhos Vera Wintermark, Max Nagy Ferenc (neurológus Kaposvár) Moizs Marianna (1964-) (orvos) Nagy Dávid Lückl János Repa Imre (1950-) (radiológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM090005
Első szerző:Cselik Zsolt
Cím:Predictive value of PET/CT based metabolic information in the modern 3D based radiotherapy treatment of head and neck can-cer patients - single institute study / Zsolt Cselik, Zoltán Tóth, András Kedves, Dávid Sipos, Omar Freihat, Tímea Vecsera, Gábor Lukács, Miklós Emri, Gábor Bajzik, Janaki Hadjiev, Imre Repa, Mariann Moizs, Árpád Kovács
Dátum:2020
Megjegyzések:Objective: The aim of the study was to evaluate the predictive value of pretreatment positron emission tomography (PET) standardized uptake value (SUVmax), standardized uptake value corrected for lean body mass (SULpeak) value, metabolic tumour volume (MTV) and total lesion glycolysis (TLG) parameters of the primary tumour assessed with PET/computed tomography (CT) in the clinical out-come in patients diagnosed with histopathologically confirmed head and neck squamous cell carcinoma. Materials and methods: Retrospective evaluation was performed using PET/CT image datasets of 52 histologically proven head and neck cancer patients in 4 weeks' prior receiving definitive chemo-radiotherapy (CRT). Positron emission tomography /CT was performed before the CRT and 12 weeks after it for response evaluation. Image data was used for target volume delineation and for specify SUVmax, SULpeak, MTV and TLG parameters of the primary tumour. According to the results of the therapeutic response evaluation two patient subgroups were created in relation to the presence or absence of viable tumour. Metabolic data from pre-treatment PET/CT and therapeutic response were correlated using Kruskal-Wallis test. Results: After completion of the CRT in 24/52 (46%) cases viable residual tumour was detected on restaging PET/CT, while in 28/52 (54%) patients showed complete remission. For the therapeutic success prediction assessment, we could not find any significant correlation with pre-treatment SUVmax and SULpeak values (P>0.44, P>0.33). Total lesion glycolysis provided nearly significant difference (P=0.052) and MTV had shown significant difference (P=0.001) between the two patient subgroups statistically. Conclusion: Simple metabolic data (SUVmax and SULpeak) from pretreatment fluorine-18-fluorodeoxyglucose (18F-FDG) PET/CT were unable to predict therapeutic response, while volumetric information containing MTV and TLG parameters proved to be more useful, thus their inclusion to risk stratification may also have additional value.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Hellenic Journal of Nuclear Medicine. - 23 : 3 (2020), p. 165-171. -
További szerzők:Tóth Zoltán Kedves András Sipos Dávid Freihat, Omar Vecsera Tímea Lukács Gábor Emri Miklós (1962-) (fizikus) Bajzik Gábor (1968-) (orvos) Hadjiev, Janaki Repa Imre (1950-) (radiológus) Moizs Marianna (1964-) (orvos) Kovács Árpád (1979-) (onkoradiológus, klinikai onkológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1